EUVIMEDEUVIMED entdecken
Crossref

Paradoxical psoriasiform skin eruption in paediatric patients with inflammatory bowel disease treated with tumour necrosis factor-α inhibitors

Daniel Hilewitz, Sharon Yacobovitz, Shiran Reiss-Huss, Manar Matar, Yael Weintraub, Dror S Shouval iD, Lev Pavlovsky, Rivka Friedland

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llae432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Daniel Hilewitz und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Psoriasis, Inflammatory Bowel Diseases, Drug Eruptions, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumour necrosis factor α (TNF-α) inhibitor (TNFi)-induced psoriasiform eruptions are a well-known phenomenon among adults. However, data are limited regarding this reaction in children.

Objectives

To describe in paediatric patients with inflammatory bowel disease (IBD) the clinical characteristics of TNFi-induced psoriasiform eruptions and the outcomes of various therapeutic options.

Methods

We reviewed the medical charts of paediatric patients (aged < 18 years) with IBD who developed TNFi-induced psoriasiform eruptions during 2006–2022.

Results

Among 454 patients with IBD treated with TNFis, 58 (12.8%) were diagnosed with TNFi-induced psoriasiform eruptions, of whom 51 were included in the study. The female to male ratio was 1 : 1.3. The median age at skin eruption was 14.11 [interquartile range (IQR) 12.11–16.05] years. The median elapsed time to eruption appearance was 15.00 months (IQR 7.00–24.00) after initiation of the treatment. All 51 patients were treated with topical steroids and 17 (33%) needed systemic treatment (phototherapy, methotrexate or acitretin). Sixteen of 51 patients (31%) needed to stop TNFi treatment because of an intractable eruption. Female patients, patients with inflammatory alopecia and patients who were treated with methotrexate or phototherapy were more prone to stop TNFis.

Conclusions

TNFi-induced psoriasiform eruptions are common in paediatric patients with IBD. The eruption may appear months or even years after treatment initiation. Almost one-third of the described patients had to replace their treatment because of a recalcitrant cutaneous eruption. This indicates that a multidisciplinary approach is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisInflammatory Bowel DiseasesDrug EruptionsTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsHumansFemaleMaleChildAdolescentRetrospective StudiesAdalimumabInfliximab

Substanzen

Tumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsAdalimumabInfliximab

Autor:innen und Institutionen

  • School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Centre, Petach-Tikva, Israel.
  • Division of Dermatology, Rabin Medical Center, Petah Tikva, Israel.

ORCID-Profile: Dror S Shouval

Zitieren

APA

Hilewitz, D., Yacobovitz, S., Reiss-Huss, S., Matar, M., Weintraub, Y., Shouval, D. S., Pavlovsky, L., & Friedland, R. (2025). Paradoxical psoriasiform skin eruption in paediatric patients with inflammatory bowel disease treated with tumour necrosis factor-α inhibitors. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae432

Vancouver

Hilewitz D, Yacobovitz S, Reiss-Huss S, Matar M, Weintraub Y, Shouval DS, et al. Paradoxical psoriasiform skin eruption in paediatric patients with inflammatory bowel disease treated with tumour necrosis factor-α inhibitors. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llae432

BibTeX
@article{Hilewitz2025,
  author = {Hilewitz, Daniel and Yacobovitz, Sharon and Reiss-Huss, Shiran and Matar, Manar and Weintraub, Yael and Shouval, Dror S and Pavlovsky, Lev and Friedland, Rivka},
  title = {Paradoxical psoriasiform skin eruption in paediatric patients with inflammatory bowel disease treated with tumour necrosis factor-α inhibitors},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llae432}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche